View allAll Photos Tagged multiple
The Daily Grill, Palm Desert, California; February 2012
It's not really a multiple exposure, of course.
The Occasional Odd Crop, my photoblog
The Occasional Odd Thought, my tumblelog
Comentarios en español estan bienvenidos.
Commentaires en français sont les bienvenus.
I like the many shadows in this one. In the upper-right corner, however, you'll see my bathroom sink, which I tried to disguise by adjusting the brightness/contrast of the shot, but there it is. When am I going to get to use an actual studio? Hopefully in the fall, when I enter college. *gasp!*
In 2017, the total incident cases of Multiple Myeloma in 8MM was 85,971. The incident cases of Multiple Myeloma in the United States was found to be 30,271 in 2017.
The market size of Multiple Myeloma in 8MM was USD 14,111 million in 2017.
Increasing incidence rate, high adoption rate of newer therapies and an increase in the Geriatric Population are some of the key market drivers for Multiple Myeloma.
The key players in the Multiple Myeloma Market includes GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, AbbVie, Roche, Janssen Biotech, Nanjing Legend Biotech, Oncopeptides AB, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Celgene, RAPA Therapeutics, Pfizer, Cellectar Biosciences, BioLineRx, Aduro Biotech, ExCellThera, Takeda, Glenmark, Poseida Therapeutics, Amgen, Precision BioSciences, Juno Therapeutics, Molecular Partners AG, Cartesian Therapeutics, AstraZeneca, MorphoSys AG, I-Mab Biopharma and Chipscreen Biosciences.
For more detailed information on Multiple Myeloma Market, visit: www.delveinsight.com/report-store/multiple-myeloma-market
Participants just after the start of the Oxford to Cambridge Bike Ride in aid of The British Heart Foundation on 28 September 2013. Photo by Sarah Ansell.
Seen in Hong Kong
(from the archives)
© Dirk HR Spennemann 2012, All Rights Reserved
===========================================================================
I appreciate your feedback. By all means, please comment and fave!, but please do not post any comments with large group invite icons. These will be deleted.
===========================================================================
This photo has more planes than you can probably count. I like the picture because it has almost a cubist look to it. This building is also in Buenos Aires.
Tomás Saraceno's Cloud City on the roof of the Metropolitan Museum of Art. The number of visitors that can climb the Cloud City is limited and are first come first served through an elaborate process on a separate floor. A lot of museumgoers go right to the roof and are confused that they can't just climb. No advanced online reservations allowed and no extra charge to climb.
The question was, "What lessons can we learn from other disciplines?"
My answer: The ability to see the same thing in a different way, which can sometimes lead to breakthrough. In case it's not apparent, this is my attempt to replicate the optical illusion of a vase... or two faces looking at each other.